COEP Coeptis Therapeutics Holdin...

Nasdaq coeptispharma.com


$ 14.92 $ -0.29 (-1.9 %)    

Thursday, 16-Oct-2025 15:59:51 EDT
QQQ $ 591.09 $ 0.00 (0 %)
DIA $ 455.04 $ 0.00 (0 %)
SPY $ 652.32 $ 0.00 (0 %)
TLT $ 91.46 $ 0.00 (0 %)
GLD $ 399.84 $ 0.00 (0 %)
$ 15
$ 15.49
$ 2.08 x 80
$ 20.20 x 105
-- - --
$ 2.31 - $ 19.19
51,859
na
72.3M
$ 0.25
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-27-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-16-2024 06-30-2024 10-Q
6 05-10-2024 03-31-2024 10-Q
7 03-25-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-11-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 03-29-2023 12-31-2022 10-K
12 11-18-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-10-2022 03-31-2022 10-Q
15 04-08-2022 12-31-2021 10-K
16 11-16-2021 09-30-2021 10-Q
17 09-14-2021 06-30-2021 10-Q
18 07-30-2021 03-31-2021 10-Q
19 03-31-2021 12-31-2020 10-K
20 12-10-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 coeptis-therapeutics-q2-eps-117-up-from-160-yoy-sales-200681k

Coeptis Therapeutics (NASDAQ:COEP) reported quarterly losses of $(1.17) per share. This is a 26.88 percent increase over losses...

 coeptis-therapeutics-files-form-s-4-with-sec-for-proposed-merger-with-z-squared

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) ("Coeptis" or the "Company"), a next-gen technology and bioph...

 coeptis-therapeutics-snap-biosciences--monarch-therapeutics-partner-to-advance-snap-car-nk-cell-therapy

SNAP Biosciences, Inc a majority-owned subsidiary of Coeptis Therapeutics Holdings Inc.

Core News & Articles

NUBURU Poised to Finalize Strategic Acquisition and Prepare the Adoption of Advanced Technology, Artificial Intelligence & ...

 coeptis-to-merge-with-and-into-z-squared-holders-of-outstanding-z-squared-shares-to-receive-equity-in-coeptis-in-exchange-for-9000-us-based-dogecoin-mining-machines-at-closing

Coeptis Therapeutics Holdings, Inc. (Nasdaq; COEP) ("Coeptis" or the "Company"), a biopharmaceutical and techn...

 coeptis-partners-with-nexgenai-solutions-group-and-ishvara-tech-consulting-to-establish-new-co-working-technology-hub-in-india

WEXFORD, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- COEPTIS, Inc. (NASDAQ:COEP) ("the Company" or "COEPTIS"), a pi...

Core News & Articles

Shareholder Update: Strengthening Business Lines Through Innovative Applications in Blue Laser Technology, Artificial Intellige...

 coeptis-therapeutics-secures-worldwide-development-and-commercialization-rights-to-gear-cell-therapy-platform

• COEP forms GEAR Therapeutics, as a majority-owned subsidiary, to advance GEAR-modified natural killer (NK) cells into first-i...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION